What is the MPACT study?
The Methadone Patient Access to Collaborative Treatment (MPACT) study is a national trial determining whether the MPACT experimental intervention improves methadone treatment and patient outcomes. 36 Opioid Treatment Programs (OTPs) are being recruited for the study.
The MPACT intervention is a set of staff and clinic resources designed and pilot-tested by staff and patients. Led by Dr. Beth Meyerson at the University of Arizona’s Harm Reduction Research Lab, MPACT provides practical tools, training, and support to strengthen treatment quality, improve patient retention, and reduce staff stress/burnout. Join clinics nationwide that are already participating in this important study.
Why Participate?
MPACT supports patient-centered, trauma-informed methadone treatment. Designed to align with clinic workflows, it integrates easily into daily operations without disrupting care. All staff can voluntarily take advantage of MPACT resources.
Participation is Simple and Low-Burden:
- Complete a brief clinic information survey
- Designate a staff member as the clinic champion to be the study contact through the 20-month trial period
- Allow the champion to post flyers to help recruit 25 patients and 10 staff members for the study
- Take advantage of the free and easy-to-access MPACT resources available to your clinic and staff during the trial
Enrolled Clinics Receive:
- Free multidisciplinary accredited methadone training
- Other MPACT training and resources*
- Financial incentives for staff and patients who enroll to complete 5 surveys over the study period
- Financial incentives for the appointed clinic champion
*Clinics will be randomized to condition. All control clinics will have access to clinic training and clinic support tools.
All study activities are designed to fit within your clinic’s current workflow.
An Institutional Review Board responsible for human subjects research at the University of Arizona reviewed this study and found it to be acceptable, according to applicable state and federal regulations and university policy designed to protect the rights and welfare of research participants (IRB: STUDY00005677). | Research is supported by the Helping to End Addiction Long-Term® Initiative, or NIH HEAL Initiative® by the National Institute on Drug Abuse of the National Institutes of Health under Award Number R33DA059889. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health.